检索结果 - Enrico Capochiani

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)

    Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a pros... 由 Mathias Rummel, T.M. Kim, Franco Aversa, Wolfram Brugger, Enrico Capochiani, Caterina Plenteda, Francesca Re, Peter C. Trask, Stuart Osborne, Rodney B.W. Smith, Andrew Grigg

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol

    Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 由 Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, P Roncucci, Annarosa Cuccaro, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente, Edoardo Conticini, Alessandro Gozzetti, Monica Bocchia

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: